Profile
MENS VRTX REGN ALNY SGEN ARGX
Company Name Jyong Biotech Ltd. Ordinary Shares Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $743.08M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.03K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Kuo Fu-Feng Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
MENS VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 2
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Sell
Trading
MENS VRTX REGN ALNY SGEN ARGX
Last Close $10.01 $468.85 $567.74 $314.94 $228.74 $560.24
High 52 $10.44 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $7.53 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -4.12 % -9.27 % -52.76 % -5.11 % 0 % -16.6 %
Price vs. 52 Week Low 32.93 % 18.21 % 17.56 % 40.24 % 0 % 21.52 %
Total Return
MENS VRTX REGN ALNY SGEN ARGX
1 Month Return 0 % 1.91 % 8.81 % 3.37 % 0 % -4.52 %
3 Month Return 0 % -3.17 % 2.45 % 32.46 % 0 % -3.56 %
6 Month Return 0 % 14.48 % -18.53 % 32.34 % 0 % -14.63 %
9 Month Return 0 % -2.67 % -44.1 % 10.77 % 0 % 4.39 %
YTD Return 0 % 16.43 % -20.3 % 33.84 % 0 % -8.9 %
1 Year Return 0 % -4.07 % -48.39 % 20.89 % 0 % 20.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MENS VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
MENS VRTX REGN ALNY SGEN ARGX
Asset Growth -22.82 % -0.87 % 36.55 %
Gross Profit Growth - 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 45.54 % -93.69 % 128.87 %
Net Income Growth 31.39 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 28.08 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 28.08 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 28.08 % 33.84 % 938.02 %
Operating Income Growth 26.49 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -39.33 % -113.93 % 80.31 %
Operating 3 Year CFG -82.66 % -118.65 % 88.36 %
Operating 5 Year CFG -82.66 % -131.3 % -135.21 %
Operating 10 Year CFG -82.66 % 12.43 % -64 %
EPS Growth 31.43 % -114.8 % 369.77 %
EPS Diluted Growth 31.43 % -114.97 % 347.67 %
Book Value Per Share -7.18 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -56.57 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -56.57 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -56.57 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 8.65 % 116.42 % 95.27 %
Free Cash Flow Growth -39.33 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
MENS VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -47.42 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 8.55 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM 35.69 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 146.84 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -19.98 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM - 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.05 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.05 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 0.13 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -19.98 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -205.04 -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -210 -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -210 -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
MENS VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.04 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
MENS VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.04B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $-0.04B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.02B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
MENS VRTX REGN ALNY SGEN ARGX
Net Income $-0B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.24
AARD Aardvark Therapeutics, Inc. Common Stock 12.17
ABCL AbCellera Biologics Inc. 4.01
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.74
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.4
ABPWW 0.0351
ABSI Absci Corporation 2.67
ABUS Arbutus Biopharma Corporation 3.17
ABVC ABVC BioPharma, Inc. 3.97
ABVX Abivax SA American Depositary Shares 8.27
ACAD ACADIA Pharmaceuticals Inc. 20.98
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7495
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.32
ACIU AC Immune SA 2.04
Unlock